Gyon Technologies Capital Management, LP Bristol Myers Squibb CO Transaction History

Gyon Technologies Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $171,200 - $202,725	2,500 New	2,500 $179,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $77,340 - $85,178	-1,065 Reduced 16.11%	5,546 $427,000
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $406,444 - $487,362	6,611 New	6,611 $483,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $622,628 - $678,042	-10,057 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $497,209 - $559,214	-8,379 Reduced 45.45%	10,057 $635,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $802,470 - $909,346	13,898 Added 306.26%	18,436 $1.14 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $260,617 - $288,798	4,538 New	4,538 $274,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $801,142 - $1.16 Million	-17,266 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $849,659 - $1.11 Million	17,266 New	17,266 $1.11 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.